POCT

Essex Bio-Technology Posts Sound 2023 Annual Financial Results, Revenue Up 29.5%, Profit Up 22.1%

Retrieved on: 
Monday, March 18, 2024
Cloud, Research, SKQ1, Quality control, Weather, NMPA, Therapeutic Goods Administration, Environment, Best, Intelligence, Patent, Patient, Conditional sentence, Ophthalmology, Hospital, POCT, Acquisition, CMC, European Medicines Agency, GMP, City, QMS, Bevacizumab, Chemistry, Yoy, US FDA, Traction, Good, Therapy, Point-of-care testing, VISTA, Pharmaceutical industry

The Group weathered the headwinds and managed to deliver sound performances amidst the challenging trading environment in 2023.

Key Points: 
  • The Group weathered the headwinds and managed to deliver sound performances amidst the challenging trading environment in 2023.
  • As of 31 December 2023, the Group had cash and cash equivalents of approximately HK$509.8 million (2022: approximately HK$543.5 million).
  • Together with the interim dividend of HK$0.045 per ordinary share paid on 13 September 2023, the total dividend for 2023 would be HK$0.09 (2022: HK$0.065) per ordinary share.
  • The Group's turnover is primarily made up of the ophthalmology segment ("Ophthalmology") and surgical (wound care and healing) segment ("Surgical").

Syndromic Multiplex Panels Market Research Report 2024: Global Analysis, Strategies, Trends and Forecasts to 2028 with Executive Guides - ResearchAndMarkets.com

Retrieved on: 
Friday, March 29, 2024
Medical Supplies, Medical Devices, Health, Technology, Infectious Diseases, Health Technology, PCR, Disease, POCT, SARS-CoV-2, RSV, DTC, BioMérieux, STI, Live

5.2.3 Infectious Disease is Declining But..

Key Points: 
  • 5.2.3 Infectious Disease is Declining But..
    5.2.5 Economic Growth improves Living Standards.
  • 5.3.14 Syndromics drives POCT adoption.
  • 6.2 BioMerieux Submits Application for Respiratory, Sore Throat Panel
    6.8 Altratech to Enter MDx, POC Space by Supplanting PCR
    6.21 Quidel Gains CE Mark for Savanna Analyzer, Respiratory Panel
    6.26 Binx Health Targeting Clinics, DTC & OTC With STI Tests
    6.27 Luminex Lands BARDA Grant to Develop Test for SARS-CoV-2, Flu, RSV
    6.29 MiRxes Receives Approval for Multiplex SARS-CoV-2, Flu Test

Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts, Strategies and Trends, Forecasts and Executive Guides & Customization - Global Forecasts to 2029 - ResearchAndMarkets.com

Retrieved on: 
Monday, February 26, 2024
Other Health, Health, Science, Pharmaceutical, Research, POCT, DTC, RSV, Live, SARS-CoV-2, PCR, STI, Disease

5.2.3 Infectious Disease is Declining But..

Key Points: 
  • 5.2.3 Infectious Disease is Declining But..
    5.2.5 Economic Growth improves Living Standards.
  • 5.3.3 Syndrome Testing Moving to Big Instruments?
  • 5.4.6 Syndromics drives POCT adoption.
  • 5.4.7 A Big Future for PCR?

Tianlong's New Launch Gentier X3 Made its Appearance at Medlab Middle East 2024

Retrieved on: 
Thursday, February 8, 2024
Communication, Global health, KHB, Exhibition, POCT, PCR, Tourism

DUBAI, UAE, Feb. 8, 2024 /PRNewswire/ -- The 4-day Medlab Middle East 2024 at the Dubai World Trade Center came to an end successfully on February 8.

Key Points: 
  • DUBAI, UAE, Feb. 8, 2024 /PRNewswire/ -- The 4-day Medlab Middle East 2024 at the Dubai World Trade Center came to an end successfully on February 8.
  • MedLab is the largest exhibition of medical equipment in the Middle East region, attracting visitors worldwide to experience the academic atmosphere and technological innovation.
  • On Medlab 2024, Tianlong announces its brand-new product - Gentier X3 Series Real-time PCR System, which innovates in flexibility and allows users to control three independent blocks in the same PCR system, gained popularity on the exhibition.
  • With Gentier X3, maximum 3×32-well samples can be run in three different protocols on three independent thermal blocks simultaneously.

Tianlong's New Launch Gentier X3 Made its Appearance at Medlab Middle East 2024

Retrieved on: 
Thursday, February 8, 2024
Communication, Global health, KHB, Exhibition, POCT, PCR, Tourism

DUBAI, UAE, Feb. 8, 2024 /PRNewswire/ -- The 4-day Medlab Middle East 2024 at the Dubai World Trade Center came to an end successfully on February 8.

Key Points: 
  • DUBAI, UAE, Feb. 8, 2024 /PRNewswire/ -- The 4-day Medlab Middle East 2024 at the Dubai World Trade Center came to an end successfully on February 8.
  • MedLab is the largest exhibition of medical equipment in the Middle East region, attracting visitors worldwide to experience the academic atmosphere and technological innovation.
  • On Medlab 2024, Tianlong announces its brand-new product - Gentier X3 Series Real-time PCR System, which innovates in flexibility and allows users to control three independent blocks in the same PCR system, gained popularity on the exhibition.
  • With Gentier X3, maximum 3×32-well samples can be run in three different protocols on three independent thermal blocks simultaneously.

Global Veterinary Rapid Test Kits Outlook Report 2023-2028: Market to Surge at 8.53% CAGR, Propelled by Advancements in Point of Care Testing and Expanding Pet Ownership - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 7, 2024
Health, Veterinary, Pets, Consumer, Growth, Human, Environment, Prevalence, Dog, Zoonosis, Ecosystem, Investment, Point-of-care testing, Animal, Pithing, Diabetes, Laboratory, POCT, Infection, Cat, Allergy, Idexx Laboratories, Cancer, Pet, Livestock

The "Veterinary Rapid Test Kits Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Veterinary Rapid Test Kits Market - Global Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The veterinary rapid test kits market is exhibiting considerable growth, with projections to expand at a compelling CAGR of 8.53% between 2022 and 2028.
  • The veterinary rapid test kits market is a testament to the advancing frontiers in animal health diagnostics.
  • Rapidly soaring pet ownership rates are catalyzing the demand for veterinary rapid test kits.

Global Point of Care Testing (POCT) Market Report 2023-2030: Continued Expansion of Point of Care Including Self Testing Fueling Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, January 15, 2024
Nursing, Medical Supplies, Health, Hospitals, General Health, Biotechnology, Diabetes, Medical microbiology, LFA, Infection, Mortality, Conditional sentence, Patient, Mode, Incidence, Diagnosis, Developed country, Clinic, Cancer, Government, Workplace, International Diabetes Federation, Point-of-care testing, Prevalence, POC, Nature, POCT, Physician, Growth, Medical device

The "Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles" report has been added to ResearchAndMarkets.com's offering.
  • Hence, the growing infectious diseases and chronic conditions will drive the point of care testing market over the forecast period.
  • Based on diagnostics segment, the point of care testing market is dominated by blood glucose testing segment.
  • The point of care testing market for immunoassays technology is expected to witness significant growth over the forecast timeframe.

Global Hemoglobin A1C Testing Market Forecast to 2028 - Utilizing Data-driven Insights and Innovative Assays for Enhanced Decision-making in Hemoglobin A1C Testing - ResearchAndMarkets.com

Retrieved on: 
Monday, December 18, 2023
Biotechnology, Health, Medical Devices, Point-of-care testing, Growth, Data collection, Glycated hemoglobin, POCT, Patient satisfaction

The "Global Hemoglobin A1C Testing Market, Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Hemoglobin A1C Testing Market, Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global hemoglobin A1C (HbA1c) testing market will witness significant growth driven by technological advances and the increasing adoption of point-of-care testing (POCT).
  • Real-time glucose monitoring and conventional HbA1c testing have been integrated, revolutionizing patient care by offering better treatment choices and better results.
  • Collaborations between medical device manufacturers, healthcare IT businesses, and pharmaceutical companies determine the competitive landscape in the HbA1c testing market.

EDAN's Focus on Medical Technology Advancement Shines at MEDICA 2023

Retrieved on: 
Tuesday, November 14, 2023
Attention, MEDICA, Chemistry, POCT, Hematology, Patient, Samsung SPH-i500, Laboratory, Rehabilitation, Caregiver, IVD, Cardiac output

DUSSELDORF, Germany, Nov. 14, 2023 /PRNewswire/ -- Edan Instruments Inc. (300206.SZ), a leading global provider of medical and healthcare solutions, showcased its innovative range of new products at MEDICA 2023 in Germany.

Key Points: 
  • DUSSELDORF, Germany, Nov. 14, 2023 /PRNewswire/ -- Edan Instruments Inc. (300206.SZ), a leading global provider of medical and healthcare solutions, showcased its innovative range of new products at MEDICA 2023 in Germany.
  • This grand event, anticipated to draw over 81,000 visitors and host 4,500 exhibitors from around the globe, took place from November 13 to 16.
  • By achieving technological breakthroughs, our new products symbolize a blooming era for EDAN, where innovation meets excellence, and we continue to set the bar for cutting-edge medical technology."
  • Visit EDAN in person and get hands-on experience at MEDICA at booth 9A62.

EDAN's Focus on Medical Technology Advancement Shines at MEDICA 2023

Retrieved on: 
Tuesday, November 14, 2023
Attention, MEDICA, Chemistry, POCT, Hematology, Patient, Samsung SPH-i500, Laboratory, Rehabilitation, Caregiver, IVD, Cardiac output

DUSSELDORF, Germany, Nov. 14, 2023 /PRNewswire/ -- Edan Instruments Inc. (300206.SZ), a leading global provider of medical and healthcare solutions, showcased its innovative range of new products at MEDICA 2023 in Germany.

Key Points: 
  • DUSSELDORF, Germany, Nov. 14, 2023 /PRNewswire/ -- Edan Instruments Inc. (300206.SZ), a leading global provider of medical and healthcare solutions, showcased its innovative range of new products at MEDICA 2023 in Germany.
  • This grand event, anticipated to draw over 81,000 visitors and host 4,500 exhibitors from around the globe, took place from November 13 to 16.
  • By achieving technological breakthroughs, our new products symbolize a blooming era for EDAN, where innovation meets excellence, and we continue to set the bar for cutting-edge medical technology."
  • Visit EDAN in person and get hands-on experience at MEDICA at booth 9A62.